See All Slides - tctmd.com

Slides

Presentation TCT 2014

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

Presenter: Donghun Shin

September 16, 2014

Presentation TCT 2014

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Presenter: Georgios Vlachojannis

September 16, 2014

Presentation TCT 2014

Treatment of Porcine Aneurysm Models with The Multilayer Flow Modulator

Presenter: Edel Kavanagh

September 16, 2014

Presentation TCT 2014

Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___

Presenter: Marije L?wik

September 16, 2014

Presentation TCT 2014

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Presenter: Ganesh Manoharan

September 16, 2014

Presentation TCT 2014

Long-term 25 Years Follow-up of Mitral Valvuloplasty with Single Balloon_ Independent Predictors of Survival and Event Free Survival

Presenter: Edison Peixoto

September 16, 2014

Presentation TCT 2014

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Presenter: Guy F Prado Jr

September 16, 2014

Presentation TCT 2014

Detection of Paclitaxel Contamination Resulting from the Simulated Clinical Use of Drug Coated Balloon Catheters

Presenter: Charisse Ward

September 16, 2014

Presentation TCT 2014

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Presenter: Luis Nombela-Franco

September 16, 2014

Presentation TCT 2014

Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report from NCDR

Presenter: Emmanouil Brilakis

September 16, 2014

Advertisement

Slides

Prognostic Difference of Normal Versus High Presenting Blood Pressure in Patients With Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary___

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients undergoing primary percutaneous coronary intervention: 3 Year___

Treatment of Porcine Aneurysm Models with The Multilayer Flow Modulator

Comparison of Novel Zotarolimus-Eluting Cobalt-Chromium Stents and Everolimus-Eluting Platinum-Chromium Stents in Patients of the Randomized DUTCH PEERS Trial Presenting with___

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Long-term 25 Years Follow-up of Mitral Valvuloplasty with Single Balloon_ Independent Predictors of Survival and Event Free Survival

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Detection of Paclitaxel Contamination Resulting from the Simulated Clinical Use of Drug Coated Balloon Catheters

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report from NCDR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content